Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Boserolimab (MK-5890) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Adults With Advanced Solid Tumors (MK-5890-001)

Merck Sharp & Dohme LLC · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
carcinomal1pdpharmacokineticssmall
pharmacokinetics, solid tumor, carcinoma, non-small-cell lung, triple negative breast neoplasms, programmed cell death receptor 1 (pd-1), programmed cell death receptor ligand 1 (pd-l1), programmed cell death receptor ligand 2 (pd-l2), pd-1, pdl1, pd-l1, pd-l2, interventional
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 877826
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.